We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.55% | 9.15 | 8.80 | 9.50 | 9.15 | 8.86 | 9.10 | 1,054,095 | 12:15:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.09 | 84.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/12/2017 10:37 | ONWI personally wouldn't believe a word he says. It's his personality disorder that is dictating his posting, he needs to be seen as the master of everything hence, he tries to call the tune with lies and deceit. My bet is he doesn't have 2 tanners to rub together sometimes then other times he's off to order a new BMW. IMO he's one crazy dude who needs professional help | wanderer1210_0 | |
28/12/2017 22:40 | Drdobson ..i am sure your life story is of great interest however not to me .. | inanaco | |
28/12/2017 20:17 | Well at least my potential to this BB is as a genuine poster and like probably most on here am not a scientist or pretend to be one unlike some. Whilst some of your acolytes may consider your overall contribution to be of benefit many more consider your efforts to be to the total detriment to the SCLP cause by the upset you cause to potential investors and the feuds you always instigate. Equally your posts display a complete lack of credibility on why people invest.It is very little to do with how the thing works a long as it works and what is the benefit to them including questions on finance etc. That is what Herbalife has taught me | drdobson1 | |
28/12/2017 13:03 | In fairness to anyone reading this forum, I must 'hold my hand up' When I said of Nappy = "Some folks 'DO'... others just talk" ... that was not 'strictly / totally true'... and was somewhat 'amiss of me'. To clear-up any mis-understanding, and in all fairness, I should point-out, that, when I said of Nappy ="Some folks 'DO'... others just talk" - I should have said in FULL = "Some folks 'DO'... others just talk"... But in Nappy's case = When all 'the talk' fails... HE just LIES. | the real lozan | |
28/12/2017 12:53 | Lozan why did you buy at 47p sell at 54p then claim that anybody that did was being ripped of by hype | inanaco | |
28/12/2017 12:51 | To substantially raise the dosing level in patients in order to reach therapeutic levels and reduce disease progression sounds like lozan spinning his 47p valuation ... Lozan Script writer for Satu | inanaco | |
28/12/2017 12:49 | Nappy... Like I said = Some folks 'DO'... others just talk Some folks 'DO'... YOU just FAIL . I won't mention 'I Q' | the real lozan | |
28/12/2017 12:44 | Lozan when the share price was 47p it was at its least complex point .. no enolase, adjuvants, PD1, TCR modifications, other post-translational modifications so what chance do you have now ? | inanaco | |
28/12/2017 12:10 | Oh come off it Boom, the all-in potable water portfolio is much better. Indeed, you must have seen the recent launch of the Onan Biopharmaceutical Dysentery Opportunities Fund. Let's have a tune shall we. All the way from St Simons Island, Georgia. What a voice | goyathlay | |
28/12/2017 12:10 | "lozan Has still not explained how he came to value Scancell at 47p a share." . Don't NEED to Nappy. Some folks 'DO'... others just talk Some folks 'DO'... YOU just FAIL . I won't mention 'I Q' | the real lozan | |
28/12/2017 12:04 | lozan Has still not explained how he came to value Scancell at 47p a share. | inanaco | |
28/12/2017 12:02 | Drdobson ... posts """He may well have been right on the science as it is way above my head""" thanks for highlighting your potential value to this BB. its noted | inanaco | |
28/12/2017 11:36 | Smiler, Is there a limit on how many bios you should invest in? It's obviously a very personal issue and entirely depends on individual's risk appetite and overall wealth. Maybe a better strategy might be to limit the percentage of your overall portfolio that you put into bios (or any AIM stock for that matter). Once you've done that, I would have thought that the more bios you invest in the better - spreads the risk. Even better if you invest in a selection of different fields within the sector, ie. drug developers, diagnostics, CRO's etc. Anyway, each to his own................. | bermudashorts | |
28/12/2017 11:33 | P S So I ask again = "How many followers of the trHYPE are 'on the PLUS side' ???" | the real lozan | |
28/12/2017 11:12 | rHatton - My point isn't specific to Scancell but is a much more general one. Yes you're right, the market cap is obviously the current value placed by the market on any company today. Sadly, that is not the same thing at all as a measurement of the quality of the science. | bermudashorts | |
28/12/2017 11:08 | Maybe there is a limit of how many high risk baby bio's one must set in a balanced PF | wanderer1210_0 | |
28/12/2017 10:57 | So the question is Agema If the market has it correct with VAL .. why don't you listen to it, and pile in ? as the expected doubling of the share price clearly outweighs the trebling of shares in issue over recent months, Indicating Dilution does pay ... | inanaco | |
28/12/2017 10:50 | Lozan ... you have not declared a profit since the 47p to 54p ... scancell days, generating sufficient cash flow to heat the Towers through the winter, since then you have posted like a man that never escaped that "winter of discontent" not quite sure what your proud of .. Valuing Scancell at 47p ? question is how did you value it, clearly not from a science base, as you don't have a clue. | inanaco | |
28/12/2017 10:37 | Bermudashorts But the judge is the market. The share price is what a company is worth. That may change in time. But the current value is the share price For what it’s worth. The science backers have been telling us all the share price in Scancell will change for the better for many years now. So far, for years they have been wrong. | agema | |
28/12/2017 10:25 | Boom, surely though to some degree as RG alluded in the AGM, being on AIM is a bit of a judge as I think he said if your a private company and you say your worth a billion then your worth a billion but currently AIM value us at 40 million which surely makes things like managing dilution or striking deals much harder when they feel that we are actually worth more than that? | rhatton |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions